Dr. Kerendi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1010 W 40th St
Austin, TX 78756Phone+1 512-459-8753Fax+1 512-483-6807
Education & Training
- Emory University School of MedicineFellowship, Thoracic Surgery, 2006 - 2009
- Emory University School of MedicineResidency, Surgery, 1999 - 2006
- Emory University School of MedicineClass of 1999
Certifications & Licensure
- TX State Medical License 2009 - 2024
- GA State Medical License 2000 - 2011
- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2013
Clinical Trials
- PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 8 citationsSubxiphoid Hybrid Epicardial-Endocardial Atrial Fibrillation Ablation and LAA Ligation: Initial Sub-X Hybrid MAZE Registry ResultsChristopher R. Ellis, Nitish Badhwar, David Tschopp, Matthew R. Danter, Gregory G. Jackson
JACC. Clinical Electrophysiology. 2020-12-14 - 2 citationsAtrial fibrillation symptom reduction and improved quality of life following the hybrid convergent procedure: a CONVERGE trial subanalysis.Jaswinder Gill, Karl J Crossen, Christopher Blauth, Faraz Kerendi, Saumil R Oza
Annals of Cardiothoracic Surgery. 2024-03-29 - 122 citationsHybrid Convergent Procedure for the Treatment of Persistent and Long Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical Trial.David B. DeLurgio, Karl J. Crossen, Jaswinder Gill, Christopher Blauth, Saumil Oza
Circulation. Arrhythmia and Electrophysiology. 2020-11-13
Authored Content
- Hybrid Convergent Ablation for the Treatment of Persistent and Long-Standing Persistent AF: Results of CONVERGE TrialMarch 2021
Press Mentions
- Cheerleader with Eye-Opening Heart Diagnosis Shares Warning with Fellow AthletesFebruary 23rd, 2018
- UNT Cheerleader Warns Young Athletes About Rare Heart DefectFebruary 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: